Low-Dose Denosumab May Be Effective in Maintaining BMD in Postmenopausal Osteoporosis
Researchers evaluated the efficacy of low-dose denosumab for maintaining bone mineral density in postmenopausal women with osteoporosis.
All articles by Meghna Rao
Canagliflozin May Reduce Gout-Related Adverse Events, Uric Acid Levels in T2D
Researchers investigated the effects of canagliflozin on serum urate levels and gout in patients with type 2 diabetes.
Biomarkers for BMD Changes Differ at Anatomic Sites in Osteoporosis With RA
The study identified biomarkers for changes in bone mineral density at three anatomic sites in patients with osteoporosis secondary to RA.
-
Loading...
-
Loading...
Next post in Bone Metabolism
